Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
40–70
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Postmenopausal as defined by 6 months of spontaneous amenorrhea with serum FSH levels \>40mlU/ml and estradiol \< than = 25 pg/mL or 6 weeks post-surgical bilateral oophorectomy with or without hysterectomy and FSH levels \> 40 mlU/ml and estradiol \< than = 25 pg/mL
Women reporting at least 50 moderate to severe vasomotor symptoms per week, recorded for seven consecutive days
Aged 40 to 70 years
You may not be if
No estrogen monotherapy or estrogen/progesterone containing drug products within applicable wash out period prior to screening
Use of SERMs, clonidine within 4 weeks of screening
Use of CNS active medication within 1 week of screening
Use of medications (SSRI; SNRI), herbal or dietary supplements, including black cohosh, soy, phytoestrogens or over the counter agent known to possibly be effective for the treatment of vasomotor symptoms, within 4 weeks of screening
Participation in clinical trial within 30 days
Significant medical or psychiatric illness within past 12 months
Clareo Health | Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause
